The 12th edition of iPHEX will be held from 7 to 9 September 2026 at Bharat Mandapam, New Delhi. The exhibition will bring together more than 900 Indian companies from the sector and is expected to attract over 50,000 domestic visitors.

For further information, please visit: https://www.iphex-india.com/

As an initiative of the Ministry of Commerce, iPHEX has played a pivotal role in positioning India as the “Pharmacy of the World”, showcasing the entire spectrum of pharmaceuticals and healthcare to global stakeholders. Over the years, it has become an integral part of the annual business calendar for exhibitors and trade visitors worldwide.

The event will include:

• Active Pharmaceutical Ingredients (API)
  

• Finished dosage formulations
  

• Bulk drugs and intermediates
  

• Excipients and contract manufacturing
  

• Biosimilars and vaccines
  

• Natural extracts
  

• Surgical and wound care products
  

• Animal health products
  

• Healthcare services (CROs, clinical trials, R&D, custom synthesis)
  

• Dietary supplements and nutraceuticals
  

• Vitamins and probiotics
  

A key feature of iPHEX is its focused B2B sessions, which facilitate business partnerships and opportunities for international buyers, importers, distributors, and manufacturers interested in engaging with Indian pharmaceutical companies.

Delegates are required to register on the official iPHEX-2026 portal for the selection process through the following links:

With the support of the Ministry of Commerce, Government of India, Pharmexcil will reimburse to-and-fro economy class airfare (delegates are required to purchase tickets, reimbursement as per policy) and will provide hotel accommodation during the exhibition days.